Circle Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Circle Wealth Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$220K	Buy	+1,302	New	+$223K	﹤0.01%	254
2024 Q3	–	Sell	-3,974	Closed	-$545K	–	218
2024 Q2	$545K	Hold	3,974	–	–	0.01%	156
2024 Q1	$545K	Hold	3,974	–	–	0.01%	138
2023 Q4	$540K	Hold	3,974	–	–	0.01%	133
2023 Q3	$486K	Buy	+3,974	New	+$505K	0.01%	135
2021 Q2	–	Sell	-1,815	Closed	-$273K	–	179
2021 Q1	$273K	Buy	+1,815	New	+$288K	0.04%	147

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Circle Wealth Management's IBB Position: Q1 2026 in Review

Circle Wealth Management opened a new position in iShares Biotechnology ETF (IBB) in Q1 2026: 1,302 shares worth $220K. The stake represents ﹤0.01% of the portfolio and ranks #254 among its holdings. This is a return to the name: Circle Wealth Management previously reported a position in IBB as recently as Q2 2024.

Circle Wealth Management first reported a position in IBB in Q1 2021 and has held it in 6 quarters since. The position peaked at $545K in Q2 2024. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

Circle Wealth Management held 1,302 shares of iShares Biotechnology ETF worth $220K as of Q1 2026.
iShares Biotechnology ETF was a new Circle Wealth Management position in Q1 2026.
iShares Biotechnology ETF made up ﹤0.01% of Circle Wealth Management's portfolio in Q1 2026, its #254 holding.
Circle Wealth Management first reported a position in iShares Biotechnology ETF in Q1 2021 and has held it in 6 quarters since.
Circle Wealth Management's iShares Biotechnology ETF position peaked at $545K in Q2 2024.
917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Circle Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.